Eterna Therapeutics 주식 가격. ERNA - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

개인 투자자를 위한 전문가급 도구.

프리미엄

가격

0.9032

매수가

0.89

매도가

0.95

거래량

1,127,664

0.80 일간 변동폭 0.93

0.8349 52주 범위 2.625

market_cap

4.887M

전일 종가

0.949288

개장가

0.91

최근 거래 시간

1499

0.9032

(formt)

마지막 거래 시간

재정 규모

US$ 973,043

VWAP

0.862884

평균 볼륨(3m)

35,196

발행 주식

5,410,588

배당수익률

주가수익률

-0.21

주당순이익(EPS)

-4.01

매출

68k

순이익

-21.68M

Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. 더 보기

섹터

Pharmaceutical Preparations

산업

Television Broadcast Station

웹사이트

eternatx.com

본부

Wilmington, Delaware, USA

설립됨

2022

Eterna Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ERNA. The last closing price for Eterna Therapeutics was US$0.95. Over the last year, Eterna Therapeutics shares have traded in a share price range of US$ 0.8349 to US$ 2.625.

Eterna Therapeutics currently has 5,410,588 shares in issue. The market capitalisation of Eterna Therapeutics is US$5.14 million. Eterna Therapeutics has a price to earnings ratio (PE ratio) of -0.21.

Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing

CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) announced today that it has regained compliance with Nasdaq for continued...

Form D - Notice of Exempt Offering of Securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 4 - Statement of changes in beneficial ownership of securities

Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success

CAMBRIDGE, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) today announced the successful completion of a comprehensive financial...

Form 8-K - Current report

Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases

CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) and Factor Bioscience Limited (“Factor”) today announced an exclusive...

Form ARS - Annual Report to Security Holders

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.1868	-17.1376146789	1.09	1.46	0.835	25297	1.00092604	CS
4	-0.1968	-17.8909090909	1.1	1.46	0.8349	32787	1.01724124	CS
12	-0.9568	-51.4408602151	1.86	1.92	0.8349	35196	1.13687554	CS
26	-1.4468	-61.5659574468	2.35	2.625	0.8349	20486	1.30030082	CS
52	-0.2268	-20.0707964602	1.13	2.625	0.8349	20790	1.43242343	CS
156	-3.2968	-78.4952380952	4.2	7.15	0.8349	33450	3.39223536	CS
260	-3.2968	-78.4952380952	4.2	7.15	0.8349	33450	3.39223536	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	US$ 2.5306 (42.97%)	11.98M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.6M
PULMPulmatrix Inc	US$ 6.5586 (39.54%)	5.36M
ZTEKZentek Ltd	US$ 1.2574 (29.96%)	308.31k
TFFPTFF Pharmaceuticals Inc	US$ 0.376101 (-76.49%)	9.26M
EYENEyenovia Inc	US$ 0.10185 (-70.05%)	52.61M
CTXRCitius Pharmaceuticals Inc	US$ 0.1974 (-39.89%)	11.14M
VVPRVivoPower International PLC	US$ 0.8151 (-39.62%)	2.33M
IPWiPower Inc	US$ 0.7302 (-39.15%)	1.15M
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.15B
ELABElevai Labs Inc	US$ 0.0211 (-19.47%)	373.19M
NVDANVIDIA Corporation	US$ 141.98 (-3.26%)	243.3M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	164.4M
STISolidion Technology Inc	US$ 0.44 (25.71%)	139.24M